Rajshekhar Chakraborty, Meletios-Athanasios Dimopoulos
Course Content
Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain Amyloidosis
You don't currently have access to this content